Pilot Study on Incretin Effect on the Immunological Phenotype in Healthy Subjects and in Type 1 Diabetic Subjects
Phase of Trial: Phase IV
Latest Information Update: 22 May 2018
At a glance
- Drugs Liraglutide (Primary) ; Saxagliptin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 10 Oct 2016 Status changed from active, no longer recruiting to completed.
- 16 Apr 2015 Status changed from recruiting to active, no longer recruiting, according to to ClinicalTrials.gov record.